custom image

Innate Immunity: Mechanisms and Modulation

April 12-15, 2021 | 8:00AM EDT | 12:00PM UTC | 2:00PM CEST*
*Program is in development and subject to change



 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.


Apply Here


The innate immune system is the first line of response to pathogens and tissue injury. Specialized cells have evolved mechanisms to detect microbial and distress signals and translate these into effector mechanisms that fight infections, amplify inflammation, initiate acquired immunity and eventually resolve. Although the innate immune response is usually associated with infectious disease, it has been implicated in a broad range of diseases, including cancer, autoimmunity, degenerative and vascular diseases. This conference provides multidisciplinary perspectives on innate immunity, from fundamental science to clinical aspects of disease, as well as therapeutic approaches to immune modulation. The conference program will focus on recent advances in this rapidly developing field. Presentations will provide new insights into mechanisms of microbial and distress sensing and the effector mechanisms of innate immune cells including macrophages, neutrophils, dendritic cells and innate lymphoid cells. The program will also highlight new approaches to understanding protective and pathogenic innate immune function, and emerging therapeutic opportunities for targeting these mechanisms in disease.

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission:
‣ For Short Talk Consideration: March 1, 2021
‣ For Poster Booth: March 29, 2021
ePoster / SciTalk Submission: April 1, 2021
Financial Aid Application: March 29, 2021

*Please note, abstract submission is required
in order to submit an ePoster and/or Scitalk

#VKSInnateImmunity21


Financial Aid Opportunities

Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.

Find out more about financial aid opportunities here!


Call For Abstracts

Showcase your work to global audiences on the eSymposia platform!

Submit your abstract for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program! See Abstract Deadline for Short Talk Consideration

ePoster presenters will be provided with their own dedicated page on the event website to display their work in multiple formats and interact with meeting participants. ePoster features include:

  • Abstract
  • Poster PDF for download
  • SciTalk – up to 5 minute video presentation, available on-demand
  • Live chat function to answer audience questions in real-time
  • Contact information for private follow-up discussion

To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.



Program Details



Speaking at this eSymposia



Iannis Aifantis

New York University School of Medicine, USA


Ido Amit

Weizmann Institute, Israel


Fernando D. Camargo

Boston Children's Hospital, USA


Benjamin L. Ebert

Dana-Farber Cancer Institute, USA


Patricia Ernst

University of Colorado Anschutz Medical Center, USA


E. Camilla Forsberg

University of California, Santa Cruz, USA



Margaret A. Goodell

Baylor College of Medicine, USA


H. Leighton Grimes

Cincinnati Children's Hospital Medical Center, USA


Atsushi Iwama

University of Tokyo, Japan


Catriona H.M. Jamieson

University of California, San Diego, USA


Michael G. Kharas

Memorial Sloan Kettering Cancer Center, USA


Katherine Y. King

Baylor College of Medicine, USA


Ross L. Levine

Memorial Sloan Kettering Cancer Center, USA


Cristina Lo Celso

Imperial College London, UK


Ravi Majeti

Stanford University, USA


Shannon L. McKinney-Freeman

St. Jude Children's Research Hospital, USA


Hanna K.A. Mikkola

University of California, Los Angeles, USA


Sean J. Morrison

University of Texas Southwestern Medical Center, USA


Timm Schroeder

ETH Zürich, Switzerland


Daniel Starczynowski

Cincinnati Children's Hospital Medical Center, USA


Jennifer Trowbridge

The Jackson Laboratory, USA


Kate Yen

Auron Therapeutics, USA


Leonard I. Zon

HHMI/Boston Children's Hospital, USA


More program details will be available soon.


Subscribe to receive updates to the program for this meeting.


Email address:    





Sponsors


 

sponsor-carousel-bmgf.png

 




Additional Support



 

sponsor-carousel-bmgf.png

 

Funding for this conference was made possible (in part) by Grant No. 1R13CA254442-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-cellpress.png

sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

 

sponsor-carousel-scientist.png

 



#ScienceMustGoOn


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.







The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Donate to Keystone Symposia


custom image